Literature DB >> 18418062

Cancer stem cells: Models, mechanisms and implications for improved treatment.

Jiangbing Zhou1, Ying Zhang.   

Abstract

Cancer stem cell research has drawn a lot of attention recently. The importance of cancer stem cell research lies in the possibility of providing new approaches for improved understanding of cancer biology and cancer treatment. However, cancer stem cell research is still at its infancy. In this review, we will discuss the concept of cancer stem cells and the commonly used approaches for isolating or enriching cancer stem cells. We then review the common features of cancer stem cells including resistance to cancer drugs and stresses such as hypoxia and radiation. We also summarize signaling pathways which might be preferentially important for cancer stem cells. Finally, we will propose a new Yin-Yang model of cancer stem cells and discuss the possibility of developing new drugs that target cancer stem cells for improved treatment of cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18418062     DOI: 10.4161/cc.7.10.5953

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  41 in total

1.  Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells.

Authors:  Junjie Li; Salvatore Condello; Jessica Thomes-Pepin; Xiaoxiao Ma; Yu Xia; Thomas D Hurley; Daniela Matei; Ji-Xin Cheng
Journal:  Cell Stem Cell       Date:  2016-12-29       Impact factor: 24.633

2.  Microfluidics 3D gel-island chip for single cell isolation and lineage-dependent drug responses study.

Authors:  Zhixiong Zhang; Yu-Chih Chen; Yu-Heng Cheng; Yi Luan; Euisik Yoon
Journal:  Lab Chip       Date:  2016-06-08       Impact factor: 6.799

Review 3.  Long non-coding RNAs in gastric cancer: versatile mechanisms and potential for clinical translation.

Authors:  Jing Zhao; Yongchao Liu; Guangjian Huang; Peng Cui; Wenhong Zhang; Ying Zhang
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

4.  Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapy.

Authors:  Stephen L Abrams; Linda S Steelman; John G Shelton; William Chappell; Jörg Bäsecke; Franca Stivala; Marco Donia; Ferdinando Nicoletti; Massimo Libra; Alberto M Martelli; James A McCubrey
Journal:  Cell Cycle       Date:  2010-05-15       Impact factor: 4.534

5.  Novel agent DMAMCL suppresses osteosarcoma growth and decreases the stemness of osteosarcoma stem cell.

Authors:  Gen Ba; Zhongyan Hua; Ning Xu; Simeng Zhang; Zhihui Liu; Carol J Thiele; Zhijie Li
Journal:  Cell Cycle       Date:  2020-05-13       Impact factor: 4.534

6.  Mouse sarcoma L1 cell line holoclones have a stemness signature.

Authors:  J Miloszewska; M Gos; M Przybyszewska; H Trembacz; M Koronkiewicz; P Janik
Journal:  Cell Prolif       Date:  2010-06       Impact factor: 6.831

7.  Knockdown of astrocyte elevated gene-1 (AEG-1) in cervical cancer cells decreases their invasiveness, epithelial to mesenchymal transition, and chemoresistance.

Authors:  Xiangwen Liu; Degui Wang; Huiling Liu; Ying Feng; Tianyuan Zhu; Lang Zhang; Bingdong Zhu; Ying Zhang
Journal:  Cell Cycle       Date:  2014-03-25       Impact factor: 4.534

8.  UM-SCC-103: a unique tongue cancer cell line that recapitulates the tumorigenic stem cell population of the primary tumor.

Authors:  John H Owen; Samantha J Hauff; Alice L Tang; Martin P Graham; Michael J Czerwinski; Marcella Kaddoura; Silvana Papagerakis; Carol R Bradford; Thomas E Carey; Mark E P Prince
Journal:  Ann Otol Rhinol Laryngol       Date:  2014-05-09       Impact factor: 1.547

Review 9.  The bright and the dark sides of DNA repair in stem cells.

Authors:  Guido Frosina
Journal:  J Biomed Biotechnol       Date:  2010-04-08

Review 10.  Therapeutic strategies targeting cancer stem cells.

Authors:  Xiaoyan Ning; Jianchang Shu; Yiqi Du; Qiwen Ben; Zhaoshen Li
Journal:  Cancer Biol Ther       Date:  2013-01-28       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.